| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/RHEUMATOLOGY/KEG248 |
| P698 | PubMed publication ID | 12730551 |
| P50 | author | José Delgado Alves | Q57839773 |
| David A. Isenberg | Q42326409 | ||
| P2093 | author name string | Kumar S | |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| lipoprotein | Q28350 | ||
| antibody | Q79460 | ||
| P304 | page(s) | 893-899 | |
| P577 | publication date | 2003-04-16 | |
| P1433 | published in | Rheumatology | Q7320492 |
| P1476 | title | Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome | |
| P478 | volume | 42 |
| Q36290168 | 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus |
| Q37143021 | Accelerated atherosclerosis is independent of feeding high fat diet in systemic lupus erythematosus-susceptible LDLr(-/-) mice |
| Q35108174 | Altered lipid levels in untreated patients with early polymyositis |
| Q33533540 | Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction |
| Q39377043 | Anti-apolipoprotein A-1 antibodies and carotid intima-media thickness in Egyptian women with systemic lupus erythematosus. |
| Q39534079 | Anti-erythropoietin receptor antibodies in systemic lupus erythematosus patients with anemia |
| Q46982870 | Antibodies toward high-density lipoprotein components inhibit paraoxonase activity in patients with systemic lupus erythematosus |
| Q35775322 | Antiphospholipid syndrome: multiple mechanisms |
| Q38835289 | ApoA1 and ApoA1-specific self-antibodies in cardiovascular disease |
| Q83177928 | Arterial compliance: is it reduced in antiphospholipid syndrome? |
| Q36283443 | Atherogenesis and autoimmune disease: the model of lupus |
| Q27004493 | Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity |
| Q36438919 | Autoantibodies to apolipoprotein A-1 in cardiovascular diseases: current perspectives |
| Q64262888 | Cardiac Manifestations of Antiphospholipid Syndrome With Focus on Its Primary Form |
| Q34317326 | Definition of human apolipoprotein A-I epitopes recognized by autoantibodies present in patients with cardiovascular diseases |
| Q39123611 | Dyslipidemia in systemic lupus erythematosus |
| Q90706672 | IgG Anti-high-Density Lipoproteins Antibodies Discriminate Between Arterial and Venous Events in Thrombotic Antiphospholipid Syndrome Patients |
| Q35162593 | IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study |
| Q40463756 | Invariant NKT cells limit activation of autoreactive CD1d-positive B cells. |
| Q28552664 | Novel Phospholipid-Protein Conjugates Allow Improved Detection of Antibodies in Patients with Autoimmune Diseases |
| Q35216322 | Oxidative stress in systemic lupus erythematosus and antiphospholipid syndrome: a gateway to atherosclerosis |
| Q59797299 | Progression of subclinical and clinical cardiovascular disease in a UK SLE cohort: the role of classic and SLE-related factors |
| Q54967401 | Renal Involvement in Antiphospholipid Syndrome. |
| Q86984388 | Renal involvement in antiphospholipid syndrome |
| Q37366421 | Subclinical impairment of ovarian reserve in systemic lupus erythematosus patients with normal menstruation not using alkylating therapy |
| Q45876558 | Synthesis of Phospholipid-Protein Conjugates as New Antigens for Autoimmune Antibodies. |
| Q37033345 | Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention |
| Q28072610 | The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus |
| Q37817582 | The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus? |
| Q28188901 | Therapy insight: systemic lupus erythematosus as a risk factor for cardiovascular disease |
| Q41375519 | β2-Glycoprotein I-Dependent Anti-Cardiolipin Antibodies Associated With Periodontitis in Patients With Systemic Lupus Erythematosus. |
Search more.